4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
97%
- Product Code: 124667
CAS:
10179-57-4
| Molecular Weight: | 377.46 g./mol | Molecular Formula: | C₂₁H₁₉N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00358662 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
This compound is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of enzyme inhibition. It has shown potential as an inhibitor of specific enzymes involved in inflammatory pathways, making it a candidate for the development of anti-inflammatory drugs. Additionally, its structural properties are being explored for potential applications in designing novel therapeutic agents targeting conditions such as arthritis, chronic pain, and other inflammatory disorders. Its sulfonamide group also suggests possible antibacterial properties, which could be harnessed in the development of new antibiotics. Researchers are further investigating its pharmacokinetics and pharmacodynamics to optimize its efficacy and safety for potential clinical use.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | €674.32 |
+
-
|
| 0.250 | 10-20 days | €2,360.13 |
+
-
|
4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
This compound is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of enzyme inhibition. It has shown potential as an inhibitor of specific enzymes involved in inflammatory pathways, making it a candidate for the development of anti-inflammatory drugs. Additionally, its structural properties are being explored for potential applications in designing novel therapeutic agents targeting conditions such as arthritis, chronic pain, and other inflammatory disorders. Its sulfonamide group also suggests possible antibacterial properties, which could be harnessed in the development of new antibiotics. Researchers are further investigating its pharmacokinetics and pharmacodynamics to optimize its efficacy and safety for potential clinical use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :